Industry

Instrument-Free Veros™ COVID-19 Produces Lab-Quality Molecular Results in about 15 minutes BOSTON & OXFORD, England & CAMBRIDGE, England & BRISBANE, Australia–(BUSINESS WIRE)–Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement with Abacus dx for the non-exclusive distribution in Australia and New Zealand of Sense’s Veros instrument-free, point-of-care molecular … [Read more…]

Nominations now open for the 2022 Supplier Diversity Awards, an annual program honoring the legacy of Earl G. Reubel, founder of Kerma Medical Products and longtime partner of Owens & Minor Deadline for submissions is Nov. 18; winners will be announced at the Healthcare Supplier Diversity Alliance Annual Meeting on Dec. 8 RICHMOND, Va.–(BUSINESS WIRE)–Owens … [Read more…]

DALLAS–(BUSINESS WIRE)–Secretome Therapeutics, a preclinical company developing novel therapies derived from neonatal mesenchymal stem cells, today announced the appointment of Angela Shen, M.D., M.B.A, to its Board of Directors. Dr. Shen is currently the Vice President, Strategic Innovation Leaders at Mass General Brigham and has served as Chief Medical Officer (CMO) at multiple venture-backed biotech … [Read more…]

Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities The Company Intends to Submit All Periodic Reports and Hold an Earnings Call the Week of October 17, 2022 HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”). All of the shares of common stock are being offered by Amylyx. Amylyx expects to grant the … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that management will participate in the following investor conferences during October 2022: Cantor Fitzgerald Neurology & Psychiatry Conference, October 6, in San Francisco, CA BMO Life Sciences Private Company Showcase October 13, in New York, NY Oppenheimer’s Private Company Showcase, October 17-18, … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$TNDM–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm … [Read more…]

HealthFleet is proud to recognize many clients and partners among the key participants in the conference. NEEDHAM, Mass.–(BUSINESS WIRE)–#behavioralhealth–Dr. Cate Collings, MD, MS, FACC, Dip ABLM provided expertise, guidance and support to the Biden-Harris Administration’s White House Conference on Hunger, Nutrition, and Health last week. The conference was focused on developing a transformational vision for … [Read more…]

New York’s largest provider of Medicare Advantage plans introduces a new Medicare Advantage PPO plan to provide beneficiaries with more options for seeking the care they need NEW YORK–(BUSINESS WIRE)–Healthfirst, one of the largest Medicare Advantage plans in New York,i today announced it will offer its first Medicare Advantage Preferred Provider Organization (PPO) plan for … [Read more…]

Company brings industry leadership and expertise as a founding sponsor of the initiative to make medicines more sustainable DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens today announced it is joining the Sustainable Medicines Partnership (SMP) as a founding sponsor of the initiative, which aims to collaborate and execute on projects to make the use of medicines more sustainable and … [Read more…]